Advertisement

Journal of Cancer Education

, Volume 34, Issue 1, pp 66–72 | Cite as

Racial Disparities in HPV-related Knowledge, Attitudes, and Beliefs Among African American and White Women in the USA

  • Ashley OjeagaEmail author
  • Ernest Alema-Mensah
  • Desiree Rivers
  • Ijeoma Azonobi
  • Brian Rivers
Article

Abstract

The objective of this study was to assess the differences in HPV-related knowledge, attitudes, and beliefs among African American and non-Hispanic white women and to determine their communication preferences for cancer-related information. Data was obtained from the National Cancer Institute’s (NCI) 2014 Health Interview National Trends Survey (HINTS), a cross-sectional survey of US adults 18 years of age or older. Descriptive statistics, bivariate, and multivariate logistic regression were used to identify differences in awareness and knowledge. Data was collected in 2014 and analyzed in 2016. HPV awareness (71 vs. 77%) and knowledge that HPV causes cervical cancer (64 vs. 81%) were significantly lower among blacks. Additionally, there were significant disparities in awareness of the HPV vaccine (66 vs. 79%), with only 25% of Black women indicating that they or a family member was recommended the HPV vaccine by a health care professional. There were also differences in cancer communication preferences. Blacks were more likely than Whites to trust cancer information from family (OR 2.7, confidence interval [CI] 0.725–10.048), television (OR 3.0, 95% [CI] 0.733–12.296), government health agencies (OR 5.8, [CI] 0.639–52.818), and religious organizations (OR 6.4, 95% [CI] 1.718–23.932). Study results indicate that racial/ethnic differences exist in HPV knowledge/awareness and cancer communication preferences. These results highlight the need to increase HPV prevention and education efforts using methods that are tailored to Black women. To address HPV/cervical cancer disparities, future interventions should utilize preferred communication outlets to effectively increase HPV knowledge and vaccine awareness.

Keywords

Cervical cancer prevention Health disparities Health education Human papillomavirus HPV 

Notes

Compliance with Ethical Standards

Conflict of Interest

This study was supported by Award Number U54 CA118638 from the National Institutes of Health. The National Institutes of Health did not have any role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.

Financial Disclosure

No financial disclosures were reported by the authors of this paper.

References

  1. 1.
    American Cancer Society. (2016) Cancer facts & figures. 2016. American Cancer Society, AtlantaGoogle Scholar
  2. 2.
    Desantis CE, Siegel RL, Sauer AG et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin 66(4):290–308. doi: 10.3322/caac.21340 CrossRefGoogle Scholar
  3. 3.
    American Cancer Society (2016) Cancer facts & figures for African Americans 2016–2018. American Cancer Society, AtlantaGoogle Scholar
  4. 4.
    Walboomers JMM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19. doi: 10.1002/(sici)1096-9896(199909)189:1<12::aid-path431>3.0.co;2-f CrossRefGoogle Scholar
  5. 5.
    Viens LJ, Henley SJ, Watson M et al (2016) Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Mor Mortal Wkly Rep MMWR 65(26):661–666. doi: 10.15585/mmwr.mm6526a1 CrossRefGoogle Scholar
  6. 6.
    Centers for Disease Control and Prevention (2016) Genital HPV infection—fact sheet. http://www.cdc.gov/STD/HPV/STDFact-HPV.htm. Accessed 14 July 2016
  7. 7.
    Siddiqui MAA, Perry CM (2006) Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil): profile report 1. BioDrugs 20(5):313–316. doi: 10.2165/00063030-200620050-00006 CrossRefGoogle Scholar
  8. 8.
    Centers for Disease Control and Prevention (2010) FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 59(20):626–629Google Scholar
  9. 9.
    Petrosky E, Bocchini JA, Hariri S et al (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep 64(11):300–304Google Scholar
  10. 10.
    Robinson CL, Child A (2016) Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years—United States, 2016. MMWR Morbidity and Mortality Weekly Report MMWR Morb Mortal Wkly Rep 65(4):1–2CrossRefGoogle Scholar
  11. 11.
    Office of Disease Prevention and Health Promotion (2015) Immunization and infectious diseases. Healthy people 2020. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases. Accessed 14 July 2016
  12. 12.
    Gerend MA, Shepherd MA, Lustria MLA (2013) Increasing human papillomavirus vaccine acceptability by tailoring messages to young adult women’s perceived barriers. Sex Transm Dis 40(5):401–405. doi: 10.1097/olq.0b013e318283c8a8 CrossRefGoogle Scholar
  13. 13.
    Beavis AL, Levinson KL. 2016 Preventing cervical cancer in the United States: barriers and resolutions for HPV vaccination. Front. Oncol. 6(19). doi: 10.3389/fonc.2016.00019.
  14. 14.
    Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT (2009) Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev 18(2):363–372. doi: 10.1158/1055-9965.epi-08-0418 CrossRefGoogle Scholar
  15. 15.
    Dorell C, Yankey D, Kennedy A, Stokley S (2012) Factors that influence parental vaccination decisions for adolescents, 13 to 17 years old: national immunization survey-teen, 2010. Clin Pediatr 52(2):162–170. doi: 10.1177/0009922812468208 CrossRefGoogle Scholar
  16. 16.
    Moss JL, Reiter PL, Rimer BK, Brewer NT (2016) Collaborative patient-provider communication and uptake of adolescent vaccines. Soc Sci Med 159:100–107. doi: 10.1016/j.socscimed.2016.04.030 CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Roberts JR, Thompson D, Rogacki B et al (2015) Vaccine hesitancy among parents of adolescents and its association with vaccine uptake. Vaccine 33(14):1748–1755. doi: 10.1016/j.vaccine.2015.01.068 CrossRefGoogle Scholar
  18. 18.
    Marlow LAV, Wardle J, Forster AS, Waller J (2009) Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Community Health 63(12):1010–1015. doi: 10.1136/jech.2008.085886 CrossRefPubMedCentralPubMedGoogle Scholar
  19. 19.
    Gelman A, Nikolajski C, Schwarz EB, Borrero S (2011) Racial disparities in awareness of the human papillomavirus. J Women's Health 20(8):1165–1173. doi: 10.1111/j.1525-1446.2011.00958.x CrossRefGoogle Scholar
  20. 20.
    Ford JL (2011) Racial and ethnic disparities in human papillomavirus awareness and vaccination among young adult women. Public Health Nurs 28(6):485–493. doi: 10.1111/j.1525-1446.2011.00958.x CrossRefGoogle Scholar
  21. 21.
    Friedman AL, Shepeard H (2007) Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behavior 34(3):471–485. doi: 10.1097/lgt.0b013e318168e607 CrossRefGoogle Scholar
  22. 22.
    National Cancer Institute (2015) Health information national trends survey 4 (HINTS 4) cycle 4 methodology report. http://hints.cancer.gov/docs/Instruments/HINTS-FDA_Methodology_Report.pdf. Accessed 18 July 2016
  23. 23.
    Zimet GD (2005) Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 37(6):S17–S23. doi: 10.1016/j.jadohealth.2005.09.010 CrossRefGoogle Scholar
  24. 24.
    Rosenthal S, Weiss T, Zimet G, Ma L, Good M, Vichnin M (2011) Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine 29(5):890–895. doi: 10.1016/j.vaccine.2009.12.063 CrossRefGoogle Scholar
  25. 25.
    Jacobs EA, Rolle I, Ferrans CE, Whitaker EE, Warnecke RB (2006) Understanding African Americans’ views of the trustworthiness of physicians. J Gen Intern Med 21(6):642–647. doi: 10.1111/j.1525-1497.2006.00485.x CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© American Association for Cancer Education 2017

Authors and Affiliations

  • Ashley Ojeaga
    • 1
    Email author
  • Ernest Alema-Mensah
    • 1
  • Desiree Rivers
    • 1
  • Ijeoma Azonobi
    • 1
  • Brian Rivers
    • 1
  1. 1.Morehouse School of MedicineAtlanta, GeorgiaAtlantaUSA

Personalised recommendations